abstract |
Abstract of the Disclosure Pharmaceutical preparations for the treatment of coronary heart diseases containing as pharmacological active comp-ounds a betareceptor-blocking compound and a compound which regulates the thrombocyte function,and, optionally, an alpha-receptor-blocking agent. |